Disclosure Panels Details Page
Non-Melanoma Skin Cancer Panel - Disclosures as of 05/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Sumaira Aasi MD | None | None | None | None | 04/02/2023 |
| Murad Alam MBA,MD,MSCI | None | None | None | None | 04/25/2023 |
| Arya Amini MD | Regeneron Pharmactcls Varian Medical Systems, Inc. |
AstraZeneca Pharmaceuticals LP | None | None | 05/19/2023 |
| Kristin Bibee MD | None | None | None | None | 03/08/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Rachel Blitzblau MD,PhD | None | None | None | None | 05/02/2023 |
| Jeremy Bordeaux MD,MPH | None | None | None | None | 04/25/2023 |
| Pei-Ling Chen PhD,MD | None | None | None | None | 05/15/2023 |
| Carlo Contreras MD | The Ohio State University Innovation Studio The Ohio State University Intramural Research Program |
None | MJH life sciences Total Health Conferencing |
None | 04/19/2023 |
| Dominick DiMaio MD | None | None | None | None | 04/21/2023 |
| Jessica Donigan MD | Castle Biosciences | None | None | None | 05/08/2023 |
| Sara Espinosa PhD | None | None | None | None | 01/17/2023 |
| Jeffrey Farma MD | None | None | None | None | 04/28/2023 |
| Deborah Freedman-Cass PhD | None | None | None | None | 01/10/2023 |
| Karthik Ghosh MD | None | None | None | None | 05/15/2023 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 04/28/2023 |
| Kelly Harms PhD,MD | OncoSec | None | None | None | 04/27/2023 |
| Erin Hesler | None | None | None | None | 04/04/2023 |
| Alan Ho PhD,MD | Affyimmune Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Ayala Pharmaceuticals Bayer HealthCare Bioatla Bristol-Myers Squibb Company Eisai Inc. Elevar Genentech, Inc. GlaxoSmithKline Hookipa Kura Oncology, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation OncC4 Poseida Therapeutics Regeneron Pharmaceuticals, Inc. |
Eisai Inc. Elevar Therapeutics Exelixis Inc. ExpertConnect Kura Oncology, Inc. Merck & Co., Inc. Remix Therapeutics Rgenta |
Endocrine Society Physician Education Resource |
Alliance for Clinical Trials in Oncology cooperative group|International Thyroid Oncology Group|NCI head and neck steering committee|Rgenta | 05/01/2023 |
| Anne Holbrook PharmD,BCOP | None | None | None | None | 02/02/2023 |
| John Nicholas Lukens MD | None | None | None | None | 04/27/2023 |
| Lawrence Mark PhD,MD | None | None | None | None | 03/27/2023 |
| Beth McCullough CMSRN,RN,BS | None | None | None | None | 12/19/2022 |
| Lisa McKale | None | None | None | None | 01/30/2023 |
| Theresa Medina MD | Agenus Anaveon Bioatla, Inc Bristol-Myers Squibb Company Day One Genentech, Inc. Infla-Rx Iovance pharmaceuticals Merck & Co., Inc. Pfizer Inc. Regeneron Pharmactcls Replimune SeaGen Ultimovacs |
None | None | None | 05/01/2023 |
| Kishwer Nehal MD | None | None | None | None | 02/06/2023 |
| Paul Nghiem PhD,MD | None | Almirall | None | Society for investigative dermatology | 05/18/2023 |
| Kelly Olino MD | None | None | None | None | 03/14/2023 |
| Soo Park MD | Merck & Co., Inc. Regeneron Pharmaceuticals, Inc. |
Regeneron Pharmaceuticals, Inc. | None | None | 05/21/2023 |
| Tejesh Patel MD | None | None | None | None | 05/29/2023 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 05/11/2023 |
| Igor Puzanov MSCI,MD,FACP | NIH NCI P30CA016056 Cancer Center Support Grant - Program Leader 1.2 Calendar Months | Iovance pharmaceuticals Nektar Therapeutics Nouscom Regeneron Pharmaceuticals, Inc. |
None | Ideaya, Inc. - Stocks | 04/25/2023 |
| Jason Rich MD | NA | NA | NA | NA | Pending |
| Chrysalyne Schmults MD,MS | American Society of Dermatologic Surgery Castle Bioscience Genentech, Inc. InflaRX International Society of Dermatologic Surgery Merck & Co., Inc. NIH-NCI-R03CA252817 Novartis Pharmaceuticals Corporation Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. SCOUT CONSORTIUM |
Regeneron Pharmaceuticals, Inc. sanofi-aventis U.S. SCOUT |
None | None | 01/17/2023 |
| Aleksandar Sekulic PhD,MD | Regeneron Pharmaceuticals, Inc. Replimune |
None | None | None | 08/31/2022 |
| Ashok Shaha MD | None | None | None | None | 03/03/2023 |
| Divya Srivastava MD | Regeneron Pharmaceuticals, Inc. | None | None | None | 04/28/2023 |
| Valencia Thomas MD | None | None | None | None | 05/01/2023 |
| Puja Venkat MD | None | None | None | None | 04/06/2023 |
| Amanda Visnick OCN,RN,BSN | None | None | None | None | 02/24/2023 |
| Yaohui Gloria Xu PhD,MD | None | None | None | None | 05/28/2023 |
| Siegrid Yu MD | None | None | None | None | 05/12/2023 |
| Mehran Yusuf MD | None | None | None | None | 02/13/2023 |